|
DMTPR Launched January 1, 2004
In the fall of 2002, corporate advisors and board members recommended
that the School address the emerging gap between industrial research needs
and trained graduates with a program focused on new research in drug metabolism,
transporters and pharmacogenomics. Fifteen months later, the University
of Washington School of Pharmacy (UWSOP), along with six partner corporations,
announced the launch of the Drug Metabolism, Transport and Pharmacogenomics
Research (DMTPR) Program.
The core mission of the DMTPR program
addresses both the School and industry needs through the creation of a
national center of leadership, training, and research in drug metabolism,
transport and pharmacogenomics. Current and future DMTPR program members
benefit from:
- Focused pharmaceutical research initiatives;
- Students and fellows trained in advanced methods and
concepts that frame an integrated view of drug disposition and efficacy/toxicology;
- A national center of thought and analysis of drug
metabolism/disposition and pharmacogenomic issues.
Watch our website for more information
about the DMTPR Program or contact Ken
Thummel, Associate Dean for Research and New Initiatives and DMTPR
Program Director.
|
